Miyo Tsukamoto

435 total citations
19 papers, 247 citations indexed

About

Miyo Tsukamoto is a scholar working on Rheumatology, Radiology, Nuclear Medicine and Imaging and Immunology. According to data from OpenAlex, Miyo Tsukamoto has authored 19 papers receiving a total of 247 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Rheumatology, 6 papers in Radiology, Nuclear Medicine and Imaging and 6 papers in Immunology. Recurrent topics in Miyo Tsukamoto's work include Systemic Lupus Erythematosus Research (11 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and Immunodeficiency and Autoimmune Disorders (3 papers). Miyo Tsukamoto is often cited by papers focused on Systemic Lupus Erythematosus Research (11 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and Immunodeficiency and Autoimmune Disorders (3 papers). Miyo Tsukamoto collaborates with scholars based in Japan, Brazil and Pakistan. Miyo Tsukamoto's co-authors include Kengo Gohchi, Noriko Saitoh, Moritaka Gotoh, Juzo Matsuda, J Matsuda, Kazuo Kawasugi, Kensuke Miyake, Masami Yamanaka, Tadatoshi Kinoshita and Mutsuyoshi Kazama and has published in prestigious journals such as Clinical Infectious Diseases, Annals of the Rheumatic Diseases and British Journal of Haematology.

In The Last Decade

Miyo Tsukamoto

17 papers receiving 243 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Miyo Tsukamoto Japan	8	179	92	47	43	42	19	247
G Thibaut France	4	267 1.5×	165 1.8×	47 1.0×	33 0.8×	56 1.3×	15	348
Susan Encabo United States	6	146 0.8×	89 1.0×	42 0.9×	46 1.1×	41 1.0×	10	321
A. Calligaro Italy	11	246 1.4×	117 1.3×	40 0.9×	34 0.8×	74 1.8×	23	338
D. Wahl France	5	178 1.0×	118 1.3×	38 0.8×	18 0.4×	49 1.2×	17	266
Erika Chang Canada	8	270 1.5×	141 1.5×	43 0.9×	34 0.8×	80 1.9×	9	325
Vinicius Domingues United States	8	267 1.5×	135 1.5×	29 0.6×	49 1.1×	49 1.2×	12	335
Virginie Dufrost France	10	272 1.5×	210 2.3×	33 0.7×	48 1.1×	39 0.9×	21	402
FJ López-Longo Spain	9	251 1.4×	42 0.5×	59 1.3×	42 1.0×	151 3.6×	19	308
C.D. Kooijman Netherlands	6	153 0.9×	100 1.1×	30 0.6×	11 0.3×	60 1.4×	8	294
RHWM Derksen Netherlands	9	210 1.2×	116 1.3×	35 0.7×	41 1.0×	60 1.4×	11	284

Countries citing papers authored by Miyo Tsukamoto

Since Specialization

Citations

This map shows the geographic impact of Miyo Tsukamoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miyo Tsukamoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miyo Tsukamoto more than expected).

Fields of papers citing papers by Miyo Tsukamoto

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Miyo Tsukamoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miyo Tsukamoto. The network helps show where Miyo Tsukamoto may publish in the future.

Co-authorship network of co-authors of Miyo Tsukamoto

This figure shows the co-authorship network connecting the top 25 collaborators of Miyo Tsukamoto. A scholar is included among the top collaborators of Miyo Tsukamoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Miyo Tsukamoto. Miyo Tsukamoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Tsukamoto, Miyo, Katsuya Suzuki, Nathalie Séta, & Tsutomu Takeuchi. (2017). FRI0401 Initial manifestation determines clinical entity and course in patients with anti-centromere antibody: a single center longitudinal retrospective cohort study. Annals of the Rheumatic Diseases. 76. 639–639.

Ohkado, Akihiro, et al.. (2011). Strengthening tuberculosis patient referral mechanisms among health facilities in Punjab, Pakistan. The International Journal of Tuberculosis and Lung Disease. 15(10). 1362–1366. 7 indexed citations

Matsuda, J, Noriko Saitoh, Moritaka Gotoh, et al.. (1996). PHOSPHATTDYL SERINE-DEPENDENT ANTIPROTHROMBIN ANTIBODY IS EXCLUSIVE TO PATIENTS WITH LUPUS ANTICOAGULANT. Lara D. Veeken. 35(6). 589–591. 36 indexed citations

Matsuda, Juzo, Kengo Gohchi, Kazuo Kawasugi, et al.. (1995). Inhibitory activity of anti‐β₂‐glycoprotein I antibody on factor va degradation by activated‐protein C and its cofactor protein S. American Journal of Hematology. 49(1). 89–91. 24 indexed citations

Matsuda, J, Noriko Saitoh, Moritaka Gotoh, et al.. (1995). High prevalence of anti-phospholipid antibodies and anti-thyroglobulin antibody in patients with hepatitis C virus infection treated with interferon-alpha.. PubMed. 90(7). 1138–41. 54 indexed citations

Matsuda, J, Noriko Saitoh, Moritaka Gotoh, Kengo Gohchi, & Miyo Tsukamoto. (1995). Prevalence of beta 2-glycoprotein I antibody in systemic lupus erythematosus patients with beta 2-glycoprotein I dependent antiphospholipid antibodies.. Annals of the Rheumatic Diseases. 54(1). 73–75. 12 indexed citations

Tsukamoto, Miyo, et al.. (1994). Anti-inflammatory and Immunosuppressive Effects of 1,6-Anhydro-3,4-dideoxy-2-furfuryl-.BETA.-D-threo-3-enopyranose (MT2221), a Novel Anhydro-enopyranose Derivative, on Experimental Animal Models.. Biological and Pharmaceutical Bulletin. 17(8). 1070–1074. 2 indexed citations

Matsuda, Juzo, Noriko Saitoh, Kengo Gohchi, Moritaka Gotoh, & Miyo Tsukamoto. (1994). Detection of Beta-2-Glycoprotein-l-Dependent Antiphospholipid Antibodies and Anti-Beta-2-Glyco-protein-l Antibody in Patients with Systemic Lupus Erythematosus and in Patients with Syphilis. International Archives of Allergy and Immunology. 103(3). 239–244. 5 indexed citations

Matsuda, J, Kengo Gohchi, Moritaka Gotoh, Miyo Tsukamoto, & Noriko Saitoh. (1994). Plasma concentrations of total/free and functional protein S are not decreased in systemic lupus erythematosus patients with lupus anticoagulant and/or antiphospholipid antibodies. Annals of Hematology. 69(6). 311–315. 6 indexed citations

10.

Matsuda, J, Moritaka Gotoh, Kengo Gohchi, et al.. (1994). Clinical significance of serum 2,5-oligoadenylate synthetase and soluble interleukin-2 receptor in hemophiliacs positive and negative for human immunodeficiency virus type 1. Clinical and Diagnostic Laboratory Immunology. 1(2). 155–159.

11.

Matsuda, Juzo, et al.. (1993). β2-glycoprotein I -dependent and -independent anticardiolipin antibody in patients with end-stage renal disease. Thrombosis Research. 72(2). 109–117. 20 indexed citations

12.

Matsuda, J, Miyo Tsukamoto, Kengo Gohchi, et al.. (1993). Serum Adenosine Deaminase 2 and Neopterin Levels Are Increased in a Majority of Hemophiliacs Irrespective of Infection with Human Immunodeficiency Virus Type 1. Clinical Infectious Diseases. 16(2). 260–264. 2 indexed citations

13.

Matsuda, Juzo, et al.. (1993). Anticoagulant activity of an anti‐β₂‐glycoprotein I antibody is depentent on the presence of β₂‐glycoprotein I. American Journal of Hematology. 44(3). 187–191. 7 indexed citations

14.

Matsuda, Juzo, Noriko Saitoh, Kengo Gohchi, Moritaka Gotoh, & Miyo Tsukamoto. (1993). Distinguishing β₂‐glycoprotein I dependent (systemic lupus erythematosus type) and independent (syphilis type) anticardiolipin antibody with Tween 20. British Journal of Haematology. 85(4). 799–802. 21 indexed citations

15.

Matsuda, Juzo, et al.. (1993). Measurement of β₂‐glycoprotein i (apolipoprotein h)‐independent anticardiolipin antibody in human immunodeficiency virus‐1‐positive and‐negative hemophiliacs. American Journal of Hematology. 43(2). 146–148. 17 indexed citations

16.

Matsuda, J, et al.. (1993). High prevalence of anti-cardiolipin antibody, C1q-, C3d-, and mRF-IgG immune complexes, and anti-nuclear antibody in hemophiliacs irrespective of infection with human immunodeficiency virus type 1.. PubMed. 6(10). 1120–4. 4 indexed citations

17.

Matsuda, Juzo, Kazuo Kawasugi, Kengo Gohchi, et al.. (1992). Clinical Significance of the Venous Occlusion Test on Systemic Lupus erythematosus Patients with a Focus on Changes in Blood Levels of Tissue Plasminogen Activator, von Willebrand Factor Antigen, and Thrombomodulin. Acta Haematologica. 88(1). 22–26. 6 indexed citations

18.

Matsuda, Juzo, et al.. (1992). Effect of Total-Body Cold Exposure on Plasma Concentrations of von Willebrand Factor, Endothelin-1 and Thrombomodulin in Systemic Lupus erythematosus Patients with or without Raynaud’s Phenomenon. Acta Haematologica. 88(4). 189–193. 20 indexed citations

19.

Kudo, Seishi, Mitsunori Yamakawa, Yutaka Imai, & Miyo Tsukamoto. (1992). Localization of blood coagulation factors in the germinal centers of human Peyer's patches.. PubMed. 7(2). 175–81. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact